Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE)

Aims: Although intensive statin therapy reduced cardiovascular risks, cardiovascular events have not been completely prevented. Probucol is a potent antioxidant and reduces tendon xanthomas in familial hypercholesterolemia patients despite reduction of high-density lipoprotein (HDL)-cholesterol (HDL...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashita, Shizuya, Arai, Hidenori, Bujo, Hideaki, Masuda, Daisaku, Ohama, Tohru, Ishibashi, Toshiyuki, Yanagi, Koji, Doi, Yasuji, Nakagawa, Satoshi, Yamashiro, Koichi, Tanabe, Kenichiro, Kita, Toru, Matsuzaki, Masunori, Saito, Yasushi, Fukushima, Masanori, Matsuzawa, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957028/
https://www.ncbi.nlm.nih.gov/pubmed/32336695
http://dx.doi.org/10.5551/jat.55327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957028/
https://www.ncbi.nlm.nih.gov/pubmed/32336695
http://dx.doi.org/10.5551/jat.55327

Ejemplares similares